Circulating Progesterone Levels and Ongoing Pregnancy Rates in Controlled Ovarian Stimulation Cycles in Assisted Reproduction Techniques

Shailja Verma; Pratap Kumar

Authors

Shailja Verma
Pratap Kumar

Keywords:

GnRH (gonadotropin releasing hormone), progesterone, IVF, leutinization

Abstract

How can we prevent premature leutinization in our IVF cycles? To help find the solution a study designed with specific exclusion criteria in an assisted reproductive centre of a tertiary care hospital was designed. In a period of 2 years 100 patients were followed up prospectively. GnRH antagonist protocol was implemented for all recruits because of shorter duration of treatment and as it prevented hyperstimulation. Specific criteria was chosen for GnRH anatagonist initiation. Serum Progesterone measurements were used to predict premature leutinization. Electro-chemiluminiscence Immunoassay using COBAS 6000 used for the measurements. Three different groups analysed in above cohort and we concluded that despite of progesterone rise pregnancy outcome was unaffected. Why is the question answered in discussion.

Downloads

How to Cite

Circulating Progesterone Levels and Ongoing Pregnancy Rates in Controlled Ovarian Stimulation Cycles in Assisted Reproduction Techniques. (2017). Global Journal of Medical Research, 17(E1), 9-14. https://medicalresearchjournal.org/index.php/GJMR/article/view/1341

Download Citation

References

T Hoff, M Quigley, Ssc Yen (1983) Hormonal dynamics mid cycle: A reevaluation. 57, 792-801.

K Huang, E Muechler, K Schwarz, M Goggin, M Graham (1986) Serum progesterone levels in women treated with human menopausal gonadotropin and human chorionic gonadotropin for in vitro fertilization. 46, 903.

A Halbersztadt, J Pajak, P Nowicki, I Jałocha (2006) Implantation and antigenicity of human endometrium. 60, 71-77.

R Legro, B Ary, R Paulson, F Stanczyk, M Sauer (1993) Pregnancy: Premature luteinization as detected by elevated serum progesterone is associated with a higher pregnancy rate in donor oocyte in-vitro fertilization. 8(9), 1506-1511.

C Venetis, E Kolibianakis, E Papinkalaou (2007) Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with probability of pregnancy in in vitro fertilization? A Survey Review And Meta-analysis. 13, 343-355.

J Younis, M Matilsky, O Radin, Ben (2001) Increased progesterone/estradiol ratio in the late follicular phase could be related to low ovarian reserve in in vitro fertilization -embryo transfer cycles with long gonadotropin -releasing hormone agonist. 76, 294-299.

William Schoolcraft, Eleanor Sinton, Terry Schlenker, David Huynh, Fredesminda Hamilton, David Meldrum (1991) Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate. 55(3), 563-566.

Paulo Serafini, Bronte Stone, John Kerin, Joel Batzofin, Patrick Quinn, Richard Marrs (1988) Occurrence of a spontaneous luteinizing hormone surge in superovulated cycles-predictive value of serum progesterone. 49(1), 86-89.

M Dirnfeld, S Goldman, Y Gonen, M Koifman, A Lissak, H Abramovic (1993) A modest increase in serum progesterone levels on the day of human chorionic gonadotropin (hCG) administration may influence pregnancy rate and pregnancy loss in in vitro fertilization -embryo transfer patients. 10(2), 126-130.

Marcelle Cedars, Eric Surey, Fredesminda Hamilton, Phillip Lapolt, David Meldrum (1990) Leuprolide acetate lowers circulating bioactive luteinizing hormone and testosterone concentrations during ovarian stimulation for oocyte retrieval. 53(4), 627-631.

E Adashi, C Resnick, D 'ercol E Aj, M Svoboda, J Van Wyk (1985) Insulin-like growth factors are intraovarian regulators of granulosa cell growth and functions. 6, 400-420.

H Jones (1985) Factors influencing implantation and maintenence of pregnancy following embryo transfer. 293.

N Spinks, O' Neill, C Collier, M Ryan, J (1987) Embryo derived platelet activating factor is essential in establishment of pregnancy in the mouse. 1, 106.

Kaylen Silverberg, William Burns, David Olive, Robert Riehl, Robert Schenken (1991) Serum Progesterone Levels Predict Success ofin VitroFertilization/Embryo Transfer in Patients Stimulated with Leuprolide Acetate and Human Menopausal Gonadotropins*. 73(4), 797-803.

Michael Levy, David Smotrich, Eric Widra, Arthur Sagoskin, Denise Murray, Jerry Hall (1995) The predictive value of serum progesterone and 17-OH progesterone levels onin vitro fertilization outcome. 12(3), 161-166.

F Ubaldi, M Camus, Smitz, H Bennink, A Van Steirteghem, P Devroey, R ; Fanchin, C Righini, F Olivennes, A Ferreira, R De Ziegler D, Frydman (1996) Consequences of premature progesterone elevation on the outcome of in vitro fertilization: Insights into a controversy. 68, 275-290.

R Fleming (2008) Progesterone elevation on the day of hCG: methodological issues. 14(4), 391-392.

E Bosch, E Labarta, J Crespo, C Simón, J Remohí, J Jenkins, A Pellicer (2010) Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles. 25(8), 2092-2100.

B Urman, C Alatas, S Aksoy, R Mercan, A Isiklar, B Balaban (1999) Elevated serum progesterone level on the day of hCG does not adversely affect implantation rates after intracytoplasmic sperm injection and embryo tranfer. 72, 975-979.

N Doldi, E Marsiglio, A Destafani, A Gessi, G Merati, A Ferrari (1999) Elevated serum progesterone on the day of HCG administration in IVF is associated with a higher pregnancy rate in polycystic ovary syndrome. 14(3), 601-605.

Tasuku Harada, Chieko Katagiri, Naruhisa Takao, Toshiko Toda, Yasuyuki Mio, Naoki Terakawa (1996) Altering the timing of human chorionic gonadotropin injection according to serum progesterone (P) concentrations improves embryo quality in cycles with subtle P rise. 65(3), 594-597.

Michael Harper (1992) 10 The implantation window. 6(2), 351-371.